Event rates were lower during oseltamivir-treated influenza periods and posttreatment periods vs. untreated influenza ...

(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...

(HealthDay News) — US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development, ...

Findings from key secondary endpoints showed 59.6% of patients taking orforglipron 36mg (highest dose) achieved a reduction in body weight of 10% or greater vs 8.6% of patients receiving placebo; ...

HealthDay News — Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus (T2DM), according to a study ...

Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain.

Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare ...

The Food and Drug Administration (FDA) has granted accelerated approval to Modeyso ™ (dordaviprone), a protease activator, for the treatment of adult and pediatric patients aged 1 year and older with ...

Watchful waiting extended as initial management strategy for all patients with uncomplicated acute bacterial rhinosinusitis ...

In the most severe erosive esophagitis patients (LA grade C or D), tegoprazan 100mg was found to be statistically superior to lansoprazole for maintenance of healing at 24 weeks. Noninferiority vs ...

Stronger differential effect for CPAP seen for those without excessive sleepiness, without increased blood pressure.

As part of a postmarketing requirement, Valneva will be initiating a study to assess the risk of severe chikungunya-like adverse reactions following administration of Ixchiq.